Invictus RG’s Clorox CLX Stock Holding History

Invictus RG’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,466	Closed	-$371K	–	36
2018 Q3	$371K	Buy	+2,466	New	+$350K	0.28%	96
2017 Q2	–	Sell	-3,080	Closed	-$415K	–	659
2017 Q1	$415K	Buy	+3,080	New	+$399K	0.28%	115
2016 Q4	–	Sell	-1,231	Closed	-$154K	–	656
2016 Q3	$154K	Buy	1,231 +1,047	+569%	+$137K	0.12%	324
2016 Q2	$25K	Sell	184 -689	-79%	-$89.3K	0.03%	412
2016 Q1	$110K	Buy	+873	New	+$111K	0.13%	278

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invictus RG's CLX Position: Q4 2018 in Review

Invictus RG sold out of Clorox (CLX) in Q4 2018, closing a stake of 2,466 shares — an estimated $371K sold.

Invictus RG first reported a position in CLX in Q1 2016 and held it in 5 quarters. The position peaked at $415K in Q1 2017. 989 funds tracked by Wall St. Rank hold CLX as of Q4 2018.

Invictus RG reported no remaining Clorox position as of Q4 2018 after selling out during the quarter.
Invictus RG sold 2,466 Clorox shares in Q4 2018, an estimated $371K.
Invictus RG first reported a position in Clorox in Q1 2016 and held it in 5 quarters.
Invictus RG's Clorox position peaked at $415K in Q1 2017.
989 funds tracked by Wall St. Rank held Clorox as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.